FeesSafety
Pluang+

Tactile Medical Q3 revenue rises 7% to $91.9M, lymphedema sales grow 13%, net income dips to $7.2M

Company Fundamentals
02 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Tactile Medical Q3 revenue rises 7% to $91.9M, lymphedema sales grow 13%, net income dips to $7.2M

Tactile Systems Technology reported a 7% increase in Q3 2026 revenue to $91.9 million, driven by a 13% rise in lymphedema product sales to $81.8 million. Gross margin improved slightly to 77%, but net income fell to $7.2 million from $8.2 million a year earlier due to higher operating expenses supporting growth initiatives. The company received FDA clearance for its LymphaTech 3D Scanner and is expanding its product pipeline. It expects full-year revenue growth of 9-11% and adjusted EBITDA between $50 million and $52 million for 2026.

Tactile Systems Technology's Q3 2026 financial results provide context for readers interested in health-related companies. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 48 rose and 100 fell today. Notable movers include TVTX (Travere Therapeutics Inc. Common Stock) at USD 46.00 with a 1-day change of -8.71%, NTRA (Natera Inc. Common Stock) at USD 379.01 down 8.49%, and RMD (ResMed Inc.) at USD 231.76 down 8.33%.

More News

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
1 hour ago
Exosens reports 50.9M shares and 59.1M voting rights as of October 31, 2026

Exosens reports 50.9M shares and 59.1M voting rights as of October 31, 2026

Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...

Company Fundamentals
Neutral
4 hours ago
Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...

Company Fundamentals
Neutral
4 hours ago
Centerspace reports Q3 net income jump to $7.28/share amid property sales and merger plans with IRT.

Centerspace reports Q3 net income jump to $7.28/share amid property sales and merger plans with IRT.

Centerspace announced a net income of $7.28 per diluted share for Q3 2026, up from $3.19 in the prior year, driven by gains from selling 14 apartment communities. Despite flat same-store revenues, property expenses rose 4.2%, causing a 2.7% decline i...

Company Fundamentals
Neutral
5 hours ago
KLX Energy Services to report Q3 2026 earnings with live call on Nov 6

KLX Energy Services to report Q3 2026 earnings with live call on Nov 6

KLX Energy Services Holdings, Inc. will announce its third quarter 2026 financial results on November 6, 2026, before hosting a live conference call at 9:00 a.m. Eastern Time. Investors can join the call via phone or webcast to hear details and ask q...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App